You have 9 free searches left this month | for more free features.

glucose control

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Primary Insomnia Trial (the tiaoshen acupuncture, the common acupuncture)

Not yet recruiting
  • Primary Insomnia
  • the tiaoshen acupuncture
  • the common acupuncture
  • (no location specified)
Apr 26, 2023

Chemo-related Cognitive Dysfunction Trial in Indianapolis, Pittsburgh (Memory and Attention Adaptation Training (MAAT),

Recruiting
  • Chemotherapy-related Cognitive Dysfunction
  • Memory and Attention Adaptation Training (MAAT)
  • Supportive Therapy (ST)
  • Indianapolis, Indiana
  • +1 more
Apr 21, 2022

Pain, Acute Trial in Valinhos (Fixed Dose Combination, Etodolac, Cyclobenzaprine)

Recruiting
  • Pain, Acute
  • Fixed Dose Combination
  • +2 more
  • Valinhos, São Paulo, Brazil
    Azidus Brasil Pesquisa Científica e Desenvolvimento Ltda.
Apr 19, 2022

Unresectable Hepatocellular Carcinoma, BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma Trial in

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • +3 more
  • Resin microspheres containing yttrium-90 (Y-90)
  • Mission Hills, California
  • +15 more
Sep 15, 2022

Total Hip Arthroplasty Trial in Changzhou (esketamine sub-anesthetic,, esketamine sub-anesthetic)

Completed
  • Total Hip Arthroplasty
  • esketamine sub-anesthetic,
  • esketamine sub-anesthetic
  • Changzhou, Jiangsu, China
    ChangzhouTCMH
Oct 26, 2022

Pharmacologic Induction of Tolerance for Hypoxia & Hypothermia

Not yet recruiting
  • Hypothermia
  • +2 more
  • Prospective
  • (no location specified)
Nov 9, 2023

Liver Metastases Trial in Loma Linda (Proton, Proton Radiation)

Recruiting
  • Liver Metastases
  • Proton
  • Proton Radiation
  • Loma Linda, California
    Loma Linda University Medical Center
Feb 16, 2022

Pain, Postoperative Trial in Philadelphia (Zynrelef (Bupivacaine 60 MG / Meloxicam 1.8 MG) Per 2.3 ML Extended Release Solution,

Enrolling by invitation
  • Pain, Postoperative
  • Zynrelef (Bupivacaine 60 MG / Meloxicam 1.8 MG) Per 2.3 ML Extended Release Solution
  • +2 more
  • Philadelphia, Pennsylvania
    Rothman Orthopaedic Institute
Mar 1, 2023

Sinus Floor Augmentation, Graftless Sinus Elevation Trial in Alexandria (Fibrin Glue, T-PRF, Negative control)

Completed
  • Sinus Floor Augmentation
  • Graftless Sinus Elevation
  • Fibrin Glue
  • +2 more
  • Alexandria, Azarita, Egypt
    Outpatient Clinic of Oral and Maxillofacial Surgery Department,
Apr 14, 2023

Flexible Flatfoot Trial in Lahore (Short foot exercises, Insoles)

Recruiting
  • Flexible Flatfoot
  • Short foot exercises
  • Insoles
  • Lahore, Punjab, Pakistan
    Children Hospital Lahore
May 18, 2023

Anesthesia Care Quality Trial in Ann Arbor (precision-enhanced feedback email messages, standard feedback email messages)

Not yet recruiting
  • Anesthesia Care Quality
  • precision-enhanced feedback email messages
  • standard feedback email messages
  • Ann Arbor, Michigan
    University of Michigan
Jun 20, 2023

Hyperoxia Trial (FiO2 titration using electronic alert system)

Not yet recruiting
  • Hyperoxia
  • FiO2 titration using electronic alert system
  • (no location specified)
Jun 20, 2023

Plaque Induced Gingivitis, Mouth Diseases, Bleeding Gum Trial in Baghdad (Perhyal rinse, Chlorhexidine mouthwash, Placebo)

Recruiting
  • Plaque Induced Gingivitis
  • +3 more
  • Perhyal rinse
  • +2 more
  • Baghdad, Bab Al-Moadham, Iraq
    University of Baghdad\ College of Dentistry
Mar 14, 2023

Nonalcoholic Fatty Liver Disease in Diabetic and Prediabetic

Unknown status
  • Non Alcoholic Fatty Liver
  • fibroscan
  • (no location specified)
Dec 19, 2020

Allergic Rhinitis Trial in Konya (nursing intervention)

Completed
  • Allergic Rhinitis
  • nursing intervention
  • Konya, Turkey
    Necmettin Erbakan Universty
Apr 6, 2022

Sweetness Liking Adaptation Trial in Addison (Flavored carbonated soft drink (CSD))

Completed
  • Sweetness Liking Adaptation
  • Flavored carbonated soft drink (CSD)
  • Addison, Illinois
    BioFortis Innovation Services
Mar 23, 2022

Sweetness Liking Adaptation Trial in Mexico City (Flavored carbonated soft drink (CSD) at different sweetness levels)

Completed
  • Sweetness Liking Adaptation
  • Flavored carbonated soft drink (CSD) at different sweetness levels
  • Mexico City, Naucalpan De Juárez, Mexico
    Mérieux NutriSciences (MXNS), Electrón No. 28, Parque Industrial
Mar 23, 2022

Asthma, COPD, Long COVID Trial in Algeria (Respicure®, Standard of care)

Recruiting
  • Asthma
  • +2 more
  • Respicure®
  • Standard of care
  • Algiers, Algeria
  • +7 more
Oct 28, 2022

Lower Respiratory Infection, LRTI, Pneumonia Trial in Bhaktapur (Point-of-care lung ultrasound, Chest X-ray (digital images))

Not yet recruiting
  • Lower Respiratory Infection
  • +3 more
  • Point-of-care lung ultrasound
  • Chest X-ray (digital images)
  • Bhaktapur, Bagmati, Nepal
    Siddhi Memorial Hospital
Jun 19, 2023

Surgical Menopause Using Optical Coherence Tomography (OCT)

Completed
  • Corneal Deformity
  • +2 more
  • Optic coherence tomography
  • Batman, Turkey
    Batman education adn research hospital
Jun 17, 2023

Infant Sleep Problem Trial in Shanghai (Behavioral sleep intervention)

Not yet recruiting
  • Infant Sleep Problem
  • Behavioral sleep intervention
  • Shanghai, Shanghai, China
    Shanghai children's medicial center affiliated shanghai jiaotong
Dec 1, 2021

COPD, COPD Exacerbation Trial in Denizli (patient education, training booklet, 3 months tele health)

Completed
  • COPD
  • COPD Exacerbation
  • patient education, training booklet, 3 months tele health
  • Denizli, Turkey
    Denizli Public Hospitals Association, Buldan Chest Diseases Hosp
Jan 30, 2022

Parent-Child Relations, Parenting Trial in Stockholm (ABC 0-2 years, waiting list)

Completed
  • Parent-Child Relations
  • Parenting
  • ABC 0-2 years
  • waiting list
  • Stockholm, Sweden
    PLUS
Sep 7, 2023

Coagulopathy of Immunodermatologic Diseases

Recruiting
  • Autoimmune Bullous Dermatosis
  • Blood Draw
  • Omaha, Nebraska
    University of Nebraska Medical Center
Sep 7, 2023

Type 1 Diabetes Trial in Reading, Oxford (Insulin, Asp(B28)-)

Terminated
  • Type 1 Diabetes
  • Insulin, Asp(B28)-
  • Reading, Berkshire, United Kingdom
  • +1 more
Jan 22, 2020